| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
DIEBOLD NIXDORF, Inc
13D/A
DBD · 253651202
|
4.1% |
5/19/2025
Event 5/15/2025
|
||||
| Hein Park Capital Management LP | 4.1% | |||||
| Hein Park Capital Management GP LLC | 4.1% | |||||
| Courtney W. Carson | 4.1% | |||||
| Schedule 13G · 1 security · passive | ||||||
|
Keenova Therapeutics plc
13G
MNKTQ · G5890A102
|
5.5% |
2/13/2026
Event 12/31/2025
|
||||
| Hein Park Capital Management LP | 5.5% | |||||
| Hein Park Capital Management GP LLC | 5.5% | |||||
| Courtney W. Carson | 5.5% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.